| Title | Author(s) | Year | View Count |
 | Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients | He, LR; Zhao, HY; Li, BK; Liu, YH; Liu, MZ; Guan, XY; Bian, XW; Zeng, YX; Xie, D | 2011 | 156 |
| EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β 1 and is a predictor of outcome in ovarian carcinoma patients | Rao, ZY; Cai, MY; Yang, GF; He, LR; Mai, SJ; Hua, WF; Liao, YJ; Deng, HX; Chen, YC; Guan, XY; Zeng, YX; Kung, HF; Xie, D | 2010 | 104 |
 | Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma | Yang, GF; He, WP; Cai, MY; He, LR; Luo, JH; Deng, HX; Guan, XY; Zeng, MS; Zeng, YX; Xie, D | 2010 | 614 |
| Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients | He, LR; Zhao, HY; Li, BK; Zhang, LJ; Liu, MZ; Kung, HF; Guan, XY; Bian, XW; Zeng, YX; Xie, D | 2010 | 556 |
| High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy | He, LR; Liu, MZ; Li, BK; Jia, WH; Zhang, Y; Liao, YJ; Chen, YC; Zhang, LJ; Guan, XY; Zeng, YX; Kung, HF; Xie, D | 2010 | 455 |
| Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma | He, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Zhang, LJ; Guan, XY; Zeng, YX; Xie, D | 2009 | 159 |
| Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma. | He, LR; Liu, MZ; Li, BK; Rao, HL; Deng, HX; Guan, XY; Zeng, YX; Xie, D | 2009 | 140 |
| Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma | He, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Guan, XY; Zeng, YX; Xie, D | 2009 | 183 |
|
